3.
Before entry into force of this Regulation and after consultation of the Committee for Proprietary Medicinal Products, Parts A and B of the Annex as regards medicinal products for human use shall be re-examined in the light of scientific and technical progress with a view to making any amendments necessary which will be adopted under the procedure laid down in Article 72.
← 2. · All articles · 4. →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.